RA Capital Management, L.P. 13D and 13G filings for Design Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-14 5:00 pm Sale |
2023-11-14 | 13G | Design Therapeutics, Inc. DSGN |
RA Capital Management, L.P. | 0 0.000% |
-2,971,231 (Position Closed) |
Filing |
| 2022-10-13 4:30 pm Purchase |
2022-10-03 | 13G | Design Therapeutics, Inc. DSGN |
RA Capital Management, L.P. | 2,971,231 5.320% |
2,971,231 (New Position) |
Filing |